|
gptkbp:instanceOf
|
synthetic stimulant
cathinone derivative
|
|
gptkbp:CASNumber
|
1189805-46-6
|
|
gptkbp:category
|
entactogen
recreational drug
stimulant
substituted cathinone
|
|
gptkbp:chemicalFormula
|
C11H15NO
|
|
gptkbp:controlledBy
|
gptkb:Australia
gptkb:Canada
gptkb:China
gptkb:Germany
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:discoveredIn
|
early 2000s
|
|
gptkbp:effect
|
euphoria
increased sociability
stimulation
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:firstReported
|
2007 (Europe)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
4-Methylmethcathinone
|
|
gptkbp:IUPACName
|
2-methylamino-1-(4-methylphenyl)propan-1-one
|
|
gptkbp:legalStatus
|
gptkb:Class_B_(UK)
Schedule I (USA)
|
|
gptkbp:mainStreet
|
gptkb:MCAT
bubbles
meow meow
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
177.24 g/mol
|
|
gptkbp:otherName
|
gptkb:mephedrone
|
|
gptkbp:relatedTo
|
gptkb:MDMA
cathinone
methcathinone
|
|
gptkbp:riskFactor
|
addiction
overdose
neurotoxicity
|
|
gptkbp:routeOfAdministration
|
injection
oral
insufflation
|
|
gptkbp:sideEffect
|
anxiety
paranoia
increased heart rate
insomnia
|
|
gptkbp:usedFor
|
recreational drug
|
|
gptkbp:bfsParent
|
gptkb:29122-68-7
|
|
gptkbp:bfsLayer
|
7
|